Back

WIMOAD: Weighted Integration of Multi-omics data for Alzheimer's Disease (AD) Diagnosis

Xiao, H.; Wang, J.; Wan, S.

2024-09-27 bioinformatics
10.1101/2024.09.25.614862 bioRxiv
Show abstract

INTRODUCTIONAlzheimers disease (AD), the most prevalent subtype of dementia, is characterized by a gradual decline in brain cognitive function. Early detection is critical for initiating timely interventions that may delay the severe progression of the disease. Recent advances in next-generation sequencing (NGS) offer promising, non-invasive, and cost-effective strategies for AD screening. However, most current approaches rely on single-omics data, which may fail to capture the complex biological heterogeneity among individuals. METHODSWe introduce WIMOAD, a stacking ensemble and weighted multi-omics integration for AD diagnosis. It leverages paired gene expression and methylation data from ADNI and presents a meta learning framework for multi-cognitive stage classification during AD progression. RESULTS AND DISCUSSIONWIMOAD outperforms existing integration methods in AD diagnosis, effectively capturing complex multi-omics patterns linked to clinical outcomes. Its interpretability also facilitates the detection of novel biomarkers across different omics layers.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.